Literature DB >> 19468837

Drug abuse and hepatitis C infection as comorbid features of HIV associated neurocognitive disorder: neurocognitive and neuroimaging features.

Eileen M Martin-Thormeyer1, Robert H Paul.   

Abstract

Substance abuse and co-infection with hepatitis C (HCV) are two highly relevant determinants of neurocognitive and neuroimaging abnormalities associated with HIV. Substance abuse and HCV are common in the HIV population and there is increasing evidence that the CNS is directly compromised by these comorbid conditions via additive or synergistic processes. In this article we review the current literature regarding mechanisms of neuronal injury as well as the neuropsychological and neuroimaging signatures associated with substance abuse and HCV status among HIV patients. We discuss specific methodological challenges and threats to validity associated with studies of HIV and comorbid substance use disorders or HCV and review potential strategies for minimizing their confounding effects. Efforts to understand the interactions between HIV, substance abuse and HCV co-infection will lead to more complete models of neuropathogenesis of HIV and a greater understanding of the variability in neuropsychological expression of HIV Associated Neurocognitive Disorder.

Entities:  

Mesh:

Year:  2009        PMID: 19468837      PMCID: PMC3635478          DOI: 10.1007/s11065-009-9101-6

Source DB:  PubMed          Journal:  Neuropsychol Rev        ISSN: 1040-7308            Impact factor:   7.444


  163 in total

1.  Working memory deficits in HIV-seropositive drug users.

Authors:  J A Bartok; E M Martin; D L Pitrak; R M Novak; K J Pursell; K M Mullane; M Harrow
Journal:  J Int Neuropsychol Soc       Date:  1997-09       Impact factor: 2.892

2.  Morphine potentiates HIV-1 gp120-induced neuronal apoptosis.

Authors:  Shuxian Hu; Wen S Sheng; James R Lokensgard; Phillip K Peterson
Journal:  J Infect Dis       Date:  2005-02-10       Impact factor: 5.226

3.  Variable progression of HIV-associated dementia.

Authors:  F H Bouwman; R L Skolasky; D Hes; O A Selnes; J D Glass; T E Nance-Sproson; W Royal; G J Dal Pan; J C McArthur
Journal:  Neurology       Date:  1998-06       Impact factor: 9.910

Review 4.  A review of cognitive impairment and cerebral metabolite abnormalities in patients with hepatitis C infection.

Authors:  Daniel M Forton; Joanna M Allsop; I Jane Cox; Gavin Hamilton; Keith Wesnes; Howard C Thomas; Simon D Taylor-Robinson
Journal:  AIDS       Date:  2005-10       Impact factor: 4.177

5.  Cognitive impulsivity and HIV serostatus in substance dependent males.

Authors:  Eileen M Martin; David L Pitrak; William Weddington; Niles A Rains; Gerald Nunnally; Heather Nixon; Silvana Grbesic; Jasmin Vassileva; Antoine Bechara
Journal:  J Int Neuropsychol Soc       Date:  2004-11       Impact factor: 2.892

6.  Neurocognitive dysfunction predicts postmortem findings of HIV encephalitis.

Authors:  M Cherner; E Masliah; R J Ellis; T D Marcotte; D J Moore; I Grant; R K Heaton
Journal:  Neurology       Date:  2002-11-26       Impact factor: 9.910

7.  Differential effect of HIV infection and alcoholism on conflict processing, attentional allocation, and perceptual load: evidence from a Stroop Match-to-Sample task.

Authors:  Tilman Schulte; Eva M Mueller-Oehring; Margaret J Rosenbloom; Adolf Pfefferbaum; Edith V Sullivan
Journal:  Biol Psychiatry       Date:  2005-01-01       Impact factor: 13.382

8.  Does attention-deficit hyperactivity disorder impact the developmental course of drug and alcohol abuse and dependence?

Authors:  J Biederman; T E Wilens; E Mick; S V Faraone; T Spencer
Journal:  Biol Psychiatry       Date:  1998-08-15       Impact factor: 13.382

9.  Methamphetamine potentiates HIV-1 Tat protein-mediated activation of redox-sensitive pathways in discrete regions of the brain.

Authors:  Govinder Flora; Yong Woo Lee; Avindra Nath; Bernhard Hennig; William Maragos; Michal Toborek
Journal:  Exp Neurol       Date:  2003-01       Impact factor: 5.330

10.  Putamen hypertrophy in nondemented patients with human immunodeficiency virus infection and cognitive compromise.

Authors:  J Mimi Boer Castelo; Maureen G Courtney; Rebecca J Melrose; Chantal E Stern
Journal:  Arch Neurol       Date:  2007-09
View more
  50 in total

1.  Clinical contributors to cerebral white matter integrity in HIV-infected individuals.

Authors:  Assawin Gongvatana; Ronald A Cohen; Stephen Correia; Kathryn N Devlin; Jadrian Miles; Hakmook Kang; Hernando Ombao; Bradford Navia; David H Laidlaw; Karen T Tashima
Journal:  J Neurovirol       Date:  2011-10-01       Impact factor: 2.643

2.  Effects of HIV and early life stress on amygdala morphometry and neurocognitive function.

Authors:  Uraina S Clark; Ronald A Cohen; Lawrence H Sweet; Assawin Gongvatana; Kathryn N Devlin; George N Hana; Michelle L Westbrook; Richard C Mulligan; Beth A Jerskey; Tara L White; Bradford Navia; Karen T Tashima
Journal:  J Int Neuropsychol Soc       Date:  2012-05-24       Impact factor: 2.892

3.  Genome-wide association study of neurocognitive impairment and dementia in HIV-infected adults.

Authors:  Andrew J Levine; Susan Service; Eric N Miller; Sandra M Reynolds; Elyse J Singer; Paul Shapshak; Eileen M Martin; Ned Sacktor; James T Becker; Lisa P Jacobson; Paul Thompson; Nelson Freimer
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2012-05-24       Impact factor: 3.568

Review 4.  Brain dysfunction in the era of combination antiretroviral therapy: implications for the treatment of the aging population of HIV-infected individuals.

Authors:  Uraina S Clark; Ronald A Cohen
Journal:  Curr Opin Investig Drugs       Date:  2010-08

5.  Changes in cognitive function in women with HIV infection and early life stress.

Authors:  Georgina Spies; Christine Fennema-Notestine; Mariana Cherner; Soraya Seedat
Journal:  AIDS Care       Date:  2016-07-11

Review 6.  Care of the human immunodeficiency virus-infected menopausal woman.

Authors:  Helen Elizabeth Cejtin
Journal:  Am J Obstet Gynecol       Date:  2011-12-30       Impact factor: 8.661

7.  Substance Abuse, Hepatitis C, and Aging in HIV: Common Cofactors that Contribute to Neurobehavioral Disturbances.

Authors:  Randi Melissa Schuster; Raul Gonzalez
Journal:  Neurobehav HIV Med       Date:  2012-02-16

8.  Protective effects of higher cognitive reserve for neuropsychological and daily functioning among individuals infected with hepatitis C.

Authors:  Maiko Sakamoto; Steven Paul Woods; Michael Kolessar; Daniel Kriz; J Renee Anderson; Hannah Olavarria; Anna W Sasaki; Michael Chang; Kenneth D Flora; Jennifer M Loftis; Marilyn Huckans
Journal:  J Neurovirol       Date:  2013-09-10       Impact factor: 2.643

9.  Crack cocaine use impairs anterior cingulate and prefrontal cortex function in women with HIV infection.

Authors:  Vanessa J Meyer; Deborah M Little; Daniel A Fitzgerald; Erin E Sundermann; Leah H Rubin; Eileen M Martin; Kathleen M Weber; Mardge H Cohen; Pauline M Maki
Journal:  J Neurovirol       Date:  2014-04-24       Impact factor: 2.643

10.  Amphetamine dependence and co-morbid alcohol abuse: associations to brain cortical thickness.

Authors:  Glenn Lawyer; Petr S Bjerkan; Anders Hammarberg; Nitya Jayaram-Lindström; Johan Franck; Ingrid Agartz
Journal:  BMC Pharmacol       Date:  2010-05-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.